Patents by Inventor Julie Ann King

Julie Ann King has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Leukaemia inhibitory factor
    Publication number: 20030004098
    Abstract: The present invention provides isolated DNA molecules encoding human and murine LIF and methods of producing LIF by the expression of the isolated DNA in suitable host cells. The invention further provides human and murine LIF polypeptides, pharmaceutical compositions containing LIF, and methods of use thereof.
    Type: Application
    Filed: February 12, 2001
    Publication date: January 2, 2003
    Inventors: David Paul Gearing, Nicholas Martin Gough, Douglas James Hilton, Julie Ann King, Donald Metcalf, Edouard Collins Nice, Nicos Anthony Nicola, Richard John Simpson, Tracy Ann Willson
  • Leukaemia inhibitory factor
    Patent number: 6261548
    Abstract: The present invention provides isolated DNA molecules encoding human and murine LIF and methods of producing LIF by the expression of the isolated DNA and suitable host cells. The invention further provides human and murine LIF polypeptides, pharmaceutical compositions containing LIF, and methods of use thereof.
    Type: Grant
    Filed: April 21, 1997
    Date of Patent: July 17, 2001
    Assignee: Amrad Corporation Limited
    Inventors: David Paul Gearing, Nicholas Martin Gough, Douglas James Hilton, Julie Ann King, Donald Metcalf, Edouard Collins Nice, Nicos Anthony Nicola, Richard John Simpson, Tracy Ann Willson
  • Antibodies which bind granulocyte-macrophane colony-stimulating factor receptor
    Patent number: 6136957
    Abstract: The invention provides a recombinant or synthetic receptor or a derivative thereof, for granulocyte-macrophage colony-stimulating factor (GM-CSF). The GM-CSF receptor is useful, inter alia, in the treatment or diagnosis of GM-CSF-related diseases, and in the screening of agonists and antagonists of GM-CSF receptors. The invention further provides antibodies directed against GM-CSF receptor or derivatives thereof, and pharmaceutical compositions comprising either the GM-CSF receptor, the receptor derivative, or an antibody thereto, and methods of using thereof.
    Type: Grant
    Filed: July 16, 1997
    Date of Patent: October 24, 2000
    Assignee: Amrad Corporation Limited
    Inventors: Nicos Anthony Nicola, Nicholas Martin Gough, David Paul Gearing, Donald Metcalf, Julie Ann King
  • Leukaemia inhibitory factor
    Patent number: 5750654
    Abstract: The present invention provides isolated DNA molecules encoding human and murine LIF, and methods of producing LIF by the expression of the isolated DNA in suitable host cells. The invention further provides human and murine LIF polypeptides, pharmaceutical compositions containing LIF, and methods of use thereof.
    Type: Grant
    Filed: March 29, 1995
    Date of Patent: May 12, 1998
    Assignee: Amrad Corporation Limited
    Inventors: David Paul Gearing, Nicholas Martin Gough, Douglas James Hilton, Julie Ann King, Donald Metcalf, Edouard Collins Nice, Nicos Anthony Nicola, Richard John Simpson, Tracy Ann Willson
  • Granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof
    Patent number: 5726036
    Abstract: The invention provides a recombinant or synthetic receptor for granulocyte-macrophage colony-stimulating factor (GM-CSF) and biochemical and/or biological equivalents, homologues, or derivatives thereof. The GM-CSF receptor is useful inter alia in treatment and diagnosis of GM-CSF related diseases, and in screening of agonists and antagonists of binding of GM-CSF to its cell-bound receptors. The invention further provides nucleic acid sequences encoding GM-CSF receptor, recombinant DNA molecules comprising these sequences, and transformed hosts carrying the recombinant DNA molecules, as well as antibodies directed against GM-CSF receptor, and pharmaceutical compositions comprising either the GM-CSF receptor or antibody thereto.
    Type: Grant
    Filed: February 7, 1995
    Date of Patent: March 10, 1998
    Assignee: Amrad Corporation Limited
    Inventors: Nicos Anthony Nicola, Nicholas Martin Gough, David Paul Gearing, Donald Metcalf, Julie Ann King